676 Results

People

  1. Robson
    Robson
  2. Offit
    Offit
  3. Stadler
    Stadler
  4. Joseph
    Joseph
  5. Mandelker
    Mandelker
  6. Berger
    Berger
  7. Solit
    Solit
  8. Hudis
    Hudis
  9. Kauff
    Kauff
  10. Kemel
    Kemel

Groups

  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)
  7. Clinical Genetics Service (297)
  8. Surgery (188)
  9. Department of Pathology and Laboratory Medicine (187)
  10. Epidemiology and Biostatistics (185)
  1. "Mark Robson"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (259)
  3. Review (10)
  4. Book Section (7)
  5. Editorial (6)
  6. Guidelines (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)

More Groups

People
  1. Mark Robson (676)
  2. Kenneth Offit (280)
  3. Zsofia Stadler (116)
  4. Larry Norton (89)
  5. Vijai Joseph (79)
  6. Diana Mandelker (74)

More People

Years
  1. 2025 (2)
  2. 2024 (32)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (18)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (185)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (50)
  6. Oxford University Press (42)

More Publishers

Results (676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Implications of ductal carcinoma in situ in predicting BRCA status in Ashkenazi Jewish women
    Meeting Abstract

    Sukumvanich, P.; Wadsworth, E.; Nafa, K.; Kolachana, P.; Borgen, P. I.; Robson, M. E.; Offit, K.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • Serum peptide profiling (SPP) by mass spectrometry (MS) to identify postmenopausal women with metastatic breast cancer
    Meeting Abstract

    Smith, K. L.; Villanueva, J.; D'Andrea, G.; Moynahan, M. E.; Sklarin, N.; Norton, L.; Hudis, C.; Tempst, P.; Robson, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prevalence of BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish (AJ) families with breast cancer (BC) and pancreatic cancer (PC)
    Meeting Abstract

    Marcotrigiano, M. C.; Wadsworth, E.; Balistreri, L.; Schluger, A.; Offit, K.; Robson, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • BRCA haploinsufficiency inhuman breast tumorigenesis
    Meeting Abstract

    King, T. A.; Li, W.; Yee, C.; Gemignani, M. L.; Olvera, N.; Brogi, E.; Robson, M. E.; Offit, K.; Norton, L.; Borgen, P. I.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Four-year follow-up of outcomes following risk-reducing salpingo-oophorectomy in ORCA mutation carriers
    Meeting Abstract

    Kemel, Y.; Kauff, N. D.; Robson, M. E.; Goldfrank, D. J.; Wadsworth, E.; Diiorio, T.; Boyd, J.; Hudis, C. A.; Barakat, R. R.; Offit, K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Association of personal and family history with decision to undergo risk-reducing salpingo-oophorectomy in BRCA mutation carriers
    Meeting Abstract

    Kauff, N. D.; Wadsworth, E.; Goldfrank, D. J.; Robson, M. E.; Lee, J.; Lafaro, K.; Aaron, S.; Norton, L.; Barakat, R. R.; Offit, K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A prospective longitudinal study of the impact of adjuvant chemotherapy for breast cancer (BC) on older patients' functional status and quality of life
    Meeting Abstract

    Hurria, A.; Panageas, K.; Zuckerman, E.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Adherence to mammogram (MMG) screening guidelines in BRCA1/2 mutation carriers
    Meeting Abstract

    Goldfrank, D. J.; Lee, J.; Kauff, N. D.; Hurley, K. E.; Balistreri, L. M.; Hellawell, J.; Borgen, P. I.; Hudis, C. A.; Offit, K.; Robson, M. E.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Radiation exposure and breast cancer risk for BRCA mutation carriers
    Meeting Abstract

    Goldfrank, D. J.; Chuai, S.; Cajal, T. R. Y.; Lee, J. B.; Alonso, M. C.; Diez, O.; Baiget, M.; Kauff, N. D.; Offit, K.; Bernstein, J. L.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Increased dose-density (DD) is feasible: A pilot study of epirubicin and cyclophosphamide (EC) followed by paclitaxel (T), at 10-11 day interval with filgrastim support, for women with early breast carcinoma (BC)
    Meeting Abstract

    Fornier, M. N.; Seidman, A. D.; Lake, D.; D'Andrea, G.; Bromberg, J.; Robson, M.; Van Poznak, C. H.; Panageas, K.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save